MLYS
NASDAQ · Biotechnology
Mineralys Therapeutics Inc
$24.07
+0.79 (+3.39%)
Performance
1D
—
1W
—
1M
—
3M
-35.19%
6M
-39.81%
1Y
+43.44%
YTD
-32.60%
Open$23.12
Previous Close$23.28
Day High$24.42
Day Low$22.64
52W High$47.65
52W Low$8.24
Volume—
Avg Volume1.25M
Market Cap2.22B
P/E Ratio—
EPS$-2.96
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$33.44
Below
SMA 200
$27.93
Below
RSI (14)
35
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+287.2% upside
Current
$24.07
$24.07
Target
$93.19
$93.19
$50.31
$93.19 avg
$121.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 422.84M | 383.53M | 332.94M |
| Net Income | 48.98M | 43.51M | 33.06M |
| Profit Margin | 11.6% | 11.3% | 9.9% |
| EBITDA | 63.20M | 67.45M | 57.44M |
| Free Cash Flow | 26.85M | 26.46M | 31.26M |
| Rev Growth | +5.2% | +16.0% | +2.3% |
| Debt/Equity | 0.29 | 0.28 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |